SILVERARC CAPITAL MANAGEMENT, LLC

Holdings History for Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC)

Symbol: FULC on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.65%	+0.65%	$4,463,492	394,650	+394,650	NEW	$11.31	Q4 2025
30 Sep 2024		-0.61%	$0	0	-398,436	-100%	$8.73	Q3 2024
30 Jun 2024	0.61%	0%	$2,470,303	398,436	0		$6.20	Q2 2024
31 Mar 2024	1.1%	+1.1%	$3,761,236	398,436	+398,436	NEW	$9.44	Q1 2024
31 Dec 2021		-3%	$0	0	-185,691	-100%	$8.73	Q4 2021
30 Sep 2021	3%	+3%	$5,238,000	185,691	+185,691	NEW	$28.21	Q3 2021
30 Jun 2021		-0.8%	$0	0	-121,302	-100%	$8.73	Q2 2021
31 Mar 2021	0.8%	+0.69%	$1,429,000	121,302	+105,093	+648%	$11.78	Q1 2021
31 Dec 2020	0.12%	0%	$190,000	16,209	0		$11.72	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.